İstemi Serin
İstemi Serin publishes mostly in Hematology, Oncology and Genetics, on topics such as Multiple Myeloma Research and Treatments, Acute Myeloid Leukemia Research and Lymphoma Diagnosis and Treatment.
- World rank
- #7,668,535 of 7,710,434 ranked researchers
- Rank in Türkiye
- #116,218 of 117,622
- Works
- 124
- Citations
- 299
- Citations per work
- 2.4
What does İstemi Serin research?
İstemi Serin's work is mostly in Medicine (52%), Immunology and Microbiology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6451.6%
- Medicine6451.6%
- Everything else5242.3%
- Life Sciences86.1%
- 1Hematology24% of their works
- 2Oncology9% of their works
- 3Genetics8% of their works
- 4Immunology6% of their works
- 5Pathology and Forensic Medicine6% of their works
- 6Infectious Diseases5% of their works
Research topics
Which keywords describe İstemi Serin's research?
The keywords of their largest research topics: Prognostic Factors, Rituximab, Diagnosis Criteria, International Myeloma Working Group, Acute Myeloid Leukemia, AML, Classification and Lymphoma.
- Chemotherapy
- Clinical Characteristics
- JAK2 Mutation
- Chronic Lymphocytic Leukemia
- BCR-ABL
- Lymphoma
- Acute Myeloid Leukemia
- International Myeloma Working Group
- Rituximab
- Prognostic Factors
- Diagnosis Criteria
- AML
- Classification
- Prognostic Scoring System
- Imatinib
- Genomic Aberrations
- Myelofibrosis
- SARS-CoV-2
- Primary CNS Lymphoma
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Prognostic Factors332 topics
- Rituximab302 topics
- Diagnosis Criteria231 topic
- International Myeloma Working Group231 topic
- AML221 topic
- Acute Myeloid Leukemia221 topic
- Classification191 topic
- Lymphoma191 topic
- Prognostic Scoring System192 topics
- BCR-ABL151 topic
- Imatinib151 topic
- Chronic Lymphocytic Leukemia111 topic
- Genomic Aberrations111 topic
- JAK2 Mutation111 topic
- Myelofibrosis111 topic
- Clinical Characteristics91 topic
- SARS-CoV-291 topic
- Chemotherapy81 topic
- Primary CNS Lymphoma81 topic
Where does İstemi Serin work?
İstemi Serin's main affiliation in the publication record is Sağlık Bilimleri Üniversitesi, Türkiye.
How many publications and citations does İstemi Serin have?
OpenAlex counts 124 works and 299 citations for İstemi Serin, an h-index of 8, ranking #7,668,535 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about İstemi Serin. Posts are plain text and can be reported.